SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-128885
Filing Date
2023-12-22
Accepted
2023-12-22 17:15:22
Documents
14
Period of Report
2023-11-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2333584d1_8k.htm   iXBRL 8-K/A 30443
2 EXHIBIT 10.1 tm2333584d1_ex10-1.htm EX-10.1 13830
6 GRAPHIC tm2333584d1_ex10-1img007.jpg GRAPHIC 24763
  Complete submission text file 0001104659-23-128885.txt   257889

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA egrx-20231127.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20231127_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20231127_pre.xml EX-101.PRE 22357
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2333584d1_8k_htm.xml XML 3326
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36306 | Film No.: 231510790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)